Broadfin Holdings LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0002110839

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 Q1 2026

Q2 2026 · 1 positions · Total reported value $23.66M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 100.0% · 0 new · 1 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Broadfin Holdings LLC disclosed 1 equity positions with a combined reported value of $23.66M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were ANGO ($23.66M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Broadfin Holdings LLC opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 100.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Broadfin Holdings LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Broadfin Holdings LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 1 positions worth $23.66M in total. HoldingsHub carries 2 quarters of its filings (Q1 2026–Q2 2026).

Portfolio Structure

  • 1 positions · $23.66M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: ANGO (ANGIODYNAMICS INC) at 100.0%
  • Average position size: $23.66M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The rebalancing logic seems to reflect a conservative approach with a potential preference for stability and a focus on value. The reduction in ANGIODYNAMICS INC (ANGO) suggests caution in the health care sector, possibly reflecting concerns about the company's fundamentals or market conditions within the sector. 2. Key Moves: - Reduce: ANGIODYNAMICS INC (ANGO) by 12.1% from the previous quarter, which indicates a decrease in confidence in the company's prospects or a change in the fund's strategy within the healthcare sector. - No New Holdings: The absence of new positions suggests a lack of conviction in adding new investments this quarter. 3. Portfolio Structure: - Passive vs. Active: The lack of new positions and the reduction in a single holding indicate a passive approach, as the fund appears to be maintaining a stable portfolio rather than actively seeking new opportunities. - Sector Bias: The fund has a notable bias towards the healthcare sector, as evidenced by the significant position in ANGIODYNAMICS INC. - Risk Appetite: The reduction in ANGIODYNAMICS INC suggests a cautious risk appetite, possibly prioritizing capital preservation over aggressive growth. 4. Per-Holding One-Liner: - ANGO: ANGIODYNAMICS INC - Develops and commercializes novel therapies for cardiovascular diseases, 'unverified'. 5. One-Sentence Style Summary: This quarter, Broadfin Holdings LLC maintained a passive, cautious portfolio with a significant health care sector bias, reducing exposure to ANGIODYNAMICS INC due to potential concerns or market dynamics.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.82M $23.66M 100.00%
100.00%
Reduce

FAQ

What did Broadfin Holdings LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Broadfin Holdings LLC reported 1 equity positions worth $23.66M in aggregate; its largest disclosed positions were ANGO ($23.66M).

How large is Broadfin Holdings LLC's portfolio?

Broadfin Holdings LLC reported $23.66M of long equity holdings across 1 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Broadfin Holdings LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/broadfin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →